Ofatunumab

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Multiple Sclerosis

Phase 4

Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis

Active, not recruitingNCT06444113

Novartis PharmaceuticalsMultiple Sclerosis

Start: 2024-11-25End: 2026-10-29Updated: 2026-08-12

Unknown Phase

Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis.

CompletedNCT05576779

Novartis PharmaceuticalsMultiple Sclerosis

Start: 2020-12-03End: 2021-12-31Updated: 2022-11-08